Search research articles
Contact Us
Filters
Showing results (471-480 of 510) with videos related to
Page
of 51
Sort By:
Iscience
|
March 5, 2024
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines
Nobuhiko Ogasawara, Yoshihito Kano, Yosuke Yoneyama, et al.
Modern Rheumatology
|
September 5, 2019
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study
Sayaka Tsuda, Azusa Sameshima, Michikazu Sekine, et al.
Inflammation and Regeneration
|
November 29, 2022
Collagen type I-mediated mechanotransduction controls epithelial cell fate conversion during intestinal inflammation
Sakurako Kobayashi, Nobuhiko Ogasawara, Satoshi Watanabe, et al.
Virus Research
|
October 2, 2017
Isolation and characterization of Tarumizu tick virus: A new coltivirus from Haemaphysalis flava ticks in Japan
Ryosuke Fujita, Hiroko Ejiri, Chang-Kweng Lim, et al.
Journal of Gastroenterology
|
January 29, 2018
Single cell analysis of Crohn's disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties
Kohei Suzuki, Tatsuro Murano, Hiromichi Shimizu, et al.
Journal of Clinical Medicine
|
July 26, 2020
Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy
Keisuke Hata, Soichiro Ishihara, Yoichi Ajioka, et al.
Gastro Hep Advances
|
November 24, 2025
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
Journal of Gastroenterology
|
November 2, 2010
Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial
Toshiaki Watanabe, Yoichi Ajioka, Takayuki Matsumoto, et al.
Journal of Gastroenterology
|
December 17, 2009
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
Yuki Nishimura-Sakurai, Naoya Sakamoto, Kaoru Mogushi, et al.
Page
of 51
Search research articles
Search
Showing results (471-480 of 510) with videos related to
Sort By:
Page
of 51
Iscience
|
March 5, 2024
Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines
Nobuhiko Ogasawara, Yoshihito Kano, Yosuke Yoneyama, et al.
Modern Rheumatology
|
September 5, 2019
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study
Sayaka Tsuda, Azusa Sameshima, Michikazu Sekine, et al.
Inflammation and Regeneration
|
November 29, 2022
Collagen type I-mediated mechanotransduction controls epithelial cell fate conversion during intestinal inflammation
Sakurako Kobayashi, Nobuhiko Ogasawara, Satoshi Watanabe, et al.
Virus Research
|
October 2, 2017
Isolation and characterization of Tarumizu tick virus: A new coltivirus from Haemaphysalis flava ticks in Japan
Ryosuke Fujita, Hiroko Ejiri, Chang-Kweng Lim, et al.
Journal of Gastroenterology
|
January 29, 2018
Single cell analysis of Crohn's disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties
Kohei Suzuki, Tatsuro Murano, Hiromichi Shimizu, et al.
Journal of Clinical Medicine
|
July 26, 2020
Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy
Keisuke Hata, Soichiro Ishihara, Yoichi Ajioka, et al.
Gastro Hep Advances
|
November 24, 2025
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
Journal of Gastroenterology
|
November 2, 2010
Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial
Toshiaki Watanabe, Yoichi Ajioka, Takayuki Matsumoto, et al.
Journal of Gastroenterology
|
December 17, 2009
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
Yuki Nishimura-Sakurai, Naoya Sakamoto, Kaoru Mogushi, et al.
Page
of 51